These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31414215)

  • 1. The metabolic syndrome in heart failure: insights to specific mechanisms.
    Gargiulo P; Marsico F; Renga F; Dell'Aversana S; Esposito I; Marciano C; Dellegrottaglie S; Perrone-Filardi P; Paolillo S
    Heart Fail Rev; 2020 Jan; 25(1):1-7. PubMed ID: 31414215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.
    Paolillo S; Marsico F; Prastaro M; Renga F; Esposito L; De Martino F; Di Napoli P; Esposito I; Ambrosio A; Ianniruberto M; Mennella R; Paolillo R; Gargiulo P
    Heart Fail Clin; 2019 Jul; 15(3):341-347. PubMed ID: 31079692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
    Jia G; Whaley-Connell A; Sowers JR
    Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome in Heart Failure: Friend or Foe?
    Arcopinto M; Schiavo A; Salzano A; Bossone E; D'Assante R; Marsico F; Demelo-Rodriguez P; Baliga RR; Cittadini A; Marra AM
    Heart Fail Clin; 2019 Jul; 15(3):349-358. PubMed ID: 31079693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.
    Lam CS
    Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity.
    Komici K; Femminella GD; de Lucia C; Cannavo A; Bencivenga L; Corbi G; Leosco D; Ferrara N; Rengo G
    Aging Clin Exp Res; 2019 Mar; 31(3):321-330. PubMed ID: 29858985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vulnerable myocardium. Diabetic cardiomyopathy.
    Bugger H; Bode C
    Hamostaseologie; 2015; 35(1):17-24. PubMed ID: 25408270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The limited clinical value of a specific diabetic cardiomyopathy.
    Vigili de Kreutzenberg S; Avogaro A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for human diabetic cardiomyopathy.
    Marfella R; Sardu C; Mansueto G; Napoli C; Paolisso G
    Acta Diabetol; 2021 Aug; 58(8):983-988. PubMed ID: 33791873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic cardiomyopathy.
    Lorenzo-Almorós A; Cepeda-Rodrigo JM; Lorenzo Ó
    Rev Clin Esp (Barc); 2022 Feb; 222(2):100-111. PubMed ID: 35115137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells and diabetic cardiomyopathy: from pathology to therapy.
    Liu M; Chen H; Jiang J; Zhang Z; Wang C; Zhang N; Dong L; Hu X; Zhu W; Yu H; Wang J
    Heart Fail Rev; 2016 Nov; 21(6):723-736. PubMed ID: 27221074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of metabolic syndrome in heart failure.
    Perrone-Filardi P; Paolillo S; Costanzo P; Savarese G; Trimarco B; Bonow RO
    Eur Heart J; 2015 Oct; 36(39):2630-4. PubMed ID: 26242711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
    Dhalla NS; Shah AK; Tappia PS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.
    Dei Cas A; Spigoni V; Ridolfi V; Metra M
    Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic cardiomyopathy].
    Huang YQ; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline.
    Julián MT; Alonso N; Lupón J; Gavidia-Bovadilla G; Ferrer E; de Antonio M; López-Ayerbe J; Domingo M; Santiago-Vacas E; Zamora E; Codina P; Moliner P; Núñez J; Santesmases J; Puig-Domingo M; Bayes-Genis A
    Cardiovasc Diabetol; 2020 Mar; 19(1):38. PubMed ID: 32293458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular dysfunction and remodeling in diabetic cardiomyopathy.
    Kang Y; Wang S; Huang J; Cai L; Keller BB
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H113-H122. PubMed ID: 30412438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.
    Voulgari C; Papadogiannis D; Tentolouris N
    Vasc Health Risk Manag; 2010 Oct; 6():883-903. PubMed ID: 21057575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.